Atlas Trials

Combination Therapy Using Durvalumab and Histotripsy for Treatment of Intrahepatic Cholangiocarcinoma

Clinical trial NCT07766187 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07766187
Sponsor
University of Wisconsin, Madison
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Intrahepatic Cholangiocarcinoma
Start date
2026-08-01
Primary completion
2032-08-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.